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ARTICLE
Mapping of Deletion and Translocation Breakpoints in 1q44
Implicates the Serine/Threonine Kinase AKT3 in Postnatal
Microcephaly and Agenesis of the Corpus Callosum
Elena Boland, Jill Clayton-Smith, Victoria G. Woo, Shane McKee, Forbes D. C. Manson,
Livija Medne, Elaine Zackai, Eric A. Swanson, David Fitzpatrick, Kathleen J. Millen, Elliott H. Sherr,
William B. Dobyns, and Graeme C. M. Black
Deletions of chromosome 1q42-q44 have been reported in a variety of developmental abnormalities of the brain, including
microcephaly (MIC) and agenesis of the corpus callosum (ACC). Here, we describe detailed mapping studies of patients
with unbalanced structural rearrangements of distal 1q4. These deﬁne a 3.5-Mb critical region extending from RP11-
80B9 to RP11-241M7 that we hypothesize contains one or more genes that lead to MIC and ACC when present in only
one functional copy. Next, mapping of a balanced reciprocal t(1;13)(q44;q32) translocation in a patient with postnatal
MIC and ACC demonstrated a breakpoint within this region that is situated 20 kb upstream of AKT3, a serine-threonine
kinase. The murine orthologue Akt3 is required for the developmental regulation of normal brain size and callosal
development. Whereas sequencing of AKT3 in a panel of 45 patients with ACC did not demonstrate any pathogenic
variations, whole-mount in situ hybridization conﬁrmed expression of Akt3 in the developing central nervous system
during mouse embryogenesis. AKT3 represents an excellent candidate for developmental human MIC and ACC, and we
suggest that haploinsufﬁciency causes both postnatal MIC and ACC.
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Human geneticists have often taken advantage of struc-
tural chromosome rearrangements to map and clone hu-
man disease genes, including the causative genes for hu-
man brain and eye malformations such as holopros-
encephaly (SHH, SIX3, TGIF, and ZIC2), Dandy-Walker
malformation (ZIC1 and ZIC4), lissencephaly (DCX and
LIS1), microphthalmia (SOX2), and anterior-chamber de-
fects (FOXC1 and PAX6), among others.1–13 We have per-
formed mapping studies of six patients with rearrange-
ments of distal 1q42-q44 associated with several different
brain malformations, including congenital and postnatal
microcephaly (MIC), agenesis of the corpus callosum
(ACC [MIM 217990]), cerebellar vermis hypoplasia (CVH),
and polymicrogyria (PMG).
The abnormalities of three patients withMIC, ACC, and
CVH consist of two large interstitial deletions of distal
1q42- or 1q43-q44 and a complex unbalanced rearrange-
ment with two deleted and two inverted segments be-
tween 1q41 and 1q44. Another boy with postnatal MIC
and ACC but not CVH has an apparently balanced recip-
rocal translocation between distal 1q44 and 13q32. The
remaining patient had CVH and PMG but not MIC or
ACC and had a terminal 1q44 deletion resulting from un-
balanced segregation of a translocation between 1q44 and
11p15. We identiﬁed two genes—AKT3 and ZNF238—
closest to the chromosome 1 translocation breakpoint,
performed expression studies of mouse embryos, and se-
quenced both genes and an intervening highly conserved
noncoding sequence in a cohort of 47 patients with ACC.
Our results collectively implicate haploinsufﬁciency of
AKT3 as a cause of human MIC and ACC.
Material and Methods
Study Subjects
We ascertained six children with structural rearrangements of dis-
tal chromosome 1q who presented at our local institutions or
were referred to our research projects. Three were evaluated as
newborns with complicated neonatal courses, whereas the re-
maining three were evaluated during early childhood because of
developmental delay. All six had multiple congenital anomalies
that prompted chromosome analysis.
Subjects with ACC.—We (W.B.D. and E.H.S.) selected 55 patients
with ACC and normal chromosome analysis from our large Brain
Malformation Research Databases for sequencing of positional
candidate genes identiﬁed in the patients with 1q4 deletion and
translocation. This cohort included 11 patients with ACC only,
8 with ACC and congenital MIC (some with other brain anom-
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Table 1. OFC and Brain Malformations in Patients with 1q4 Deletion
Patienta AKT3
OFC SDb
Brain MalformationsAt Birth Later (Age)
Gentile et al.18 Deleted 2 4 (8 mo) MIC and partial ACC
Van Bever et al.19 Deleted 3 NA MIC, partial ACC, and CVH
LR04-249 Deleted 4 NA MIC, ACC, and CVH
LR05-202 Deleted 3 5 (2 years) MIC, ACC, and CVH
LR02-409 Deleted 5c 7 (5 years) MIC, partial ACC, and CVH
LR06-076 Deleted 2d 3.5 (4 years) Mild MIC and partial ACC
LR05-101 Disrupted 50th 2.5 (2 years) MIC and ACC
de Vries et al.20 Not tested NA 5 (2.5 years) MIC and partial ACC
de Vries et al.21 Not tested 2 5 (1 year) MIC and partial ACC
LP94-079 Not deleted 10th NA CVH and PMG
Daniel et al.22 Not deleted Normal Normal (15 years) None seen on CT scan
NOTE.—NApnot available.
a Patients other than those from the present study are listed by the authors who reported them.
b Or percentile.
c At age 15 wk.
d At age 4 mo.
alies), 10 with ACC and cerebellar hypoplasia, and 26 with ACC
and other anomalies.
Array Comparative Genomic Hybridization (aCGH)
aCGH was performed using a high-resolution BAC-tiling set from
the University of California–San Francisco (UCSF) Comprehen-
sive Cancer Center that contains ∼33,000 BAC PCR-based rep-
resentations, each printed once on -mm2 chromium-18# 36
coated slides.14 Before hybridization, 0.6 mg of ﬂuorometry-quan-
tiﬁed patient DNA and normal same-sex reference DNA were sep-
arately labeled with either Cy3 or Cy5 by random priming with
separate ﬂuor-conjugated 2-deoxycytidine 5-triphosphate andwere
puriﬁed from unincorporated nucleotides by spinning through a
G-50 Sephadex column. Equal amounts of Cy3-labeled patient
and Cy5-labeled reference DNAweremixed and precipitatedwith
Cot 1 DNA, then resuspended in hybridization solution and ap-
plied to the array for 48 h. Arrays were washed in a 50% for-
mamide solution and then were mounted in a 4’,6-diamidino-
2-phenylindole (DAPI) solution before imaging. Sixteen-bit
pixel DAPI, Cy3, and Cy5 images were collected2,048# 2,048
using a custom CCD camera system,5 and the data were analyzed,
using UCSF SPOT15 to automatically segment the array spots and
to calculate the log2 ratios of the total integrated Cy3 and Cy5
intensities for each spot. A second custom program, SPROC, ap-
plied quality criteria to the measurements and mapped them to
the genome, currently with use of the May 2004 freeze of the
draft sequence (UCSC Genome Bioinformatics hg17). The de-
tailed protocols for each of these methods are available on the
UCSF Comprehensive Cancer Center Web site. All aCGH results
were conﬁrmed using FISH or loss-of-heterozygosity (LOH) stud-
ies. For LOH analysis, DNA from the probands (subjects LR05-
202, LR06-076, and LR02-409), mothers (LR05-202-1 and LR06-
076-1), and fathers (LR05-202-2 and LR06-076-2) was ampliﬁed
with primers for markers spanning from 215.36 Mb to 246.19
Mb within 1q4. Primer sequences are available at the UCSC Ge-
nome Bioinformatics Web site. Products were resolved and sized
by capillary electrophoresis with use of an ABI 3730XL (Applied
Biosystems).
Deletion and Breakpoint Mapping by FISH
Deletion and breakpoint mapping by FISH was undertaken for
patients LP94-079, LR04-249, LR02-409, and LR05-101. Chromo-
some preparations were produced from peripheral-blood lym-
phocytes by conventional techniques. BAC and fosmid clones
from the regions of interest were identiﬁed from the Ensembl
genome database. They were labeled with Spectrum Green or
Spectrum Orange (Vysis), with use of nick translation. FISH was
performed using standard methods, and images were captured
using a cooled CCD camera and Smart Capture software (Applied
Imaging). To provide conﬁrmation for patients LP94-079, LR02-
409, and LR05-101, each FISH experiment was undertaken using
breakpoint-spanning clones for which 15 good-quality meta-
phase images were studied, as well as 5 or more good-quality
metaphase images for the remaining clones. We had only a small
archival sample for deceased patient LR04-249, which prevented
the use of metaphase spreads. FISH signals were instead sought
in interphase cells, and 5–10 cells were imaged.
Sequencing of AKT3, UC.43, and ZNF238
Primer sequences for the coding exons of AKT3 and ZNF238, as
well as the ultraconserved element UC.43 located within intron
1 of AKT3,16 were obtained from the Primer3 database (primers
and PCR conditions are available on request). Amplicons were
engineered to span the entire transcribed sequence of the two
genes, including the 5′ and 3′ UTRs, and the entire reported se-
quence of UC.43. However, primers designed to sequence the
ﬁnal 249 bp of the coding sequence of ZNF238 did not amplify
on genomic DNA, so this region was not sequenced. The products
were puriﬁed using Sephacryl media (GE Healthcare) with Dur-
apore (Millipore) polyvinylidene diﬂuoride columns, and ampli-
cons were then sequenced by the DNA Sequencing and Geno-
typing Core at the University of Chicago. The reactions used a
1/4 volume BigDye 3.1 terminator kit protocol, with standard
cycling conditions, for 35 cycles with use of 1.2 ml template and
1.2 ml primer. Runs were done on the 3730XL instrument from
Applied Biosystems, with use of standard 2-h runs. Sequence data
were analyzed using Sequencher (Gene Codes) sequence-analysis
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Figure 1. Brain-imaging abnormalities in patients with deletion 1q4, shown with T1-weighted midline sagittal (left column), T2-
weighted low axial (middle column), and T2-weighted higher axial (right column) sequences in an unaffected 3-year-old child (LR06-
130) (A–C) and in patients LR05-202 (D–F), LR06-076 (G–I), LR02-409 (J–L), and LR05-101 (M–O). In the normal scans, the corpus
callosum is marked by an asterisk (*) (A and C), and the inferior margin of the vermis is marked by a solid white horizontal line at
the level of the obex (A). In the images of the four patients, the corpus callosum is either absent (white arrows in panels D and M
and two black arrows in panels F and O) or small with a narrow body and absent splenium (white arrow in panels G and J and single
black arrow indicating absent posterior callosum in panels I and L). The cerebellar vermis is small in three patients who have the 1q4
deletion, with the inferior margin (dashed white lines in panels D, G, and J) located well above the level of the obex (solid white lines
in panels D, G, and J). The vermis appears mildly small in the boy with the 1q;13q translocation, with a mildly reduced anterior-
posterior diameter of the vermis resulting in an enlarged cisterna magna extending behind the cerebellum (M), even though the inferior
vermis is located near the level of the obex (dashed and solid lines in panel M). The cerebellar hemispheres are normal (E, H, K, and
N), and the fourth ventricle is normal (E, H, and N) or mildly enlarged (“4V” in panel K). Lower-resolution images of our other two
patients (LP94-079 and LR04-249) are shown in ﬁgure 2.
software and were compared with annotated sequence from the
National Center for Bioinformatics.
Analysis of Expression of Znf238 and Akt3 by In Situ
Hybridization
Whole-mount in situ expression analysis was conducted on CD1
mouse embryos at embryonic day 10.5 (E10.5) and E12.5, as de-
scribed elsewhere.17 For timed pregnancies, noon of the vaginal-
plug date was E0.5. Antisense and sense probes were generated
by in vitro transcription from Research Genetics mouse IMAGE
clones 6417039 (Znf238) and 30089997 (Akt3), which were ﬁrst
sequenced to conﬁrm identity.
Results
Clinical Details of Study Subjects
We studied a group of six patients with deletions of distal
1q42-q44 that are all associated with developmental brain
malformations (table 1 and ﬁgs. 1 and 2).
LP94-079.—This girl was born at term,with a birthweight
of 2.9 kg, length of 48 cm (both 25th percentile), and an
occipitofrontal circumference (OFC) of 31.75 cm (10th
percentile), and she had low blood glucose. Family history
was signiﬁcant for multiple miscarriages in close relatives
and a paternal cousin who died with probable hydroceph-
alus; the pregnancy was complicated by polyhydramnios.
Examination demonstrated a high forehead with vertical
furrowing, hypertelorism, mildly large tongue, small jaw,
low posterior hairline, widely spaced nipples, mild rhi-
zomelic shortening of all limbs, short ﬁngers with mildly
broad distal phalanges, ﬁfth-ﬁnger clinodactyly, abnormal
palmar and plantar creases, and anteriorly displaced anus.
She did not have organomegaly. Echocardiogram demon-
strated patent foramen ovale, secundum atrial septal de-
fect, small patent ductus, and moderate tricuspid valve
insufﬁciency. Cranial CT scan showed thick and irregular
cortex, consistent with PMG in the posterior frontal and
perisylvian regions, best seen on the right, as well as severe
CVH and a small occipital cephalocele (ﬁg. 2A–2C). The
corpus callosum appeared normal. She died at age 12 d
from complications of supraventricular tachycardia.
LR04-249.—This boy was born prematurely, at 35 wk
gestation, because of preterm labor. His birth weight was
1.35 kg (3 SD), length was 36.5 cm (4 SDs), and OFC
was 25 cm (4 SD). His primary medical problems were
intestinal obstruction, anemia secondary to ABO incom-
patability, and increasingly frequent episodes of desatur-
ation, which led to his death at age 6 wk. He had obvious
growth retardation, including severe MIC, low-set ears,
long smooth philtrum, thin lips, small jaw, high-narrow
palate, severe hypospadias, undescended testes, and sacral
dimple. Further tests demonstrated patent foramen ovale,
mild right-atrial enlargement, abnormal “domed” pulmo-
nary valve, dilatation of the right pulmonary artery, mi-
crocolon with intestinal obstruction, small kidneys with
renal insufﬁciency, 13 pairs of ribs, and butterﬂy vertebrae
at T5 and T10. Brain magnetic resonance imaging (MRI)
showed a very immature gyral pattern, even for 35 wk
gestation, that suggests a possible cortical malformation
(type uncertain); mildly enlarged andwidely separated lat-
eral ventricles; total ACC; andmoderate CVH (ﬁg. 2D–2F).
LR05-202.—This girl was born at term after a pregnancy
complicated by abnormal triple-screen results. However,
level II ultrasound was normal, so the family did not pro-
ceed with amniocentesis. At birth, she had MIC with a
birth OFC of 30.5 cm (3 SD), two ventricular septal de-
fects, and a single palmar crease. OFC was 38.5 cm at age
7 mo (4 SD) and 41 cm at age 2 years (5 SD). She was
noted to have delays in cognitive, ﬁne and gross motor,
and social skills. Seizures began at age 8.5 mo and led to
an evaluation that included brain MRI. At age 2.5 years,
her seizures were well controlled with phenobarbitol treat-
ment. A review of systems revealed corrected myopia;
three small ventricular septal defects, two of which had
closed; mild eczema; history of urinary-tract infections;
mildly distended right renal pelvis on kidney ultrasound;
and allergy to milk. She had hypotonia, a broad nasal
bridge, low-set ears, short webbed neck, epicanthal folds,
and small jaw. She was able to crawl, pull herself to a stand-
ing position, and vocalize, although she does not use in-
telligible words. Brain MRI at age 8 mo revealed a normal
gyral pattern, total ACC, mildly enlarged third and lateral
ventricles, markedly reduced white-matter volume, small
bilateral Probst bundles, and mild CVH (ﬁg. 1D–1F).
LR06-076.—This boy was born at term; birth OFC is not
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available, although it was described as borderline small.
His OFC was 39.5 cm at age 4 mo (2 SD), 41 cm at age
9 mo, 45 cm at age 30 mo, and 46 cm at age 4 years (last
three values approximately3.5 SD). Generalized seizures
began at age 2.5 years and have been partially controlled
with phenobarbital and valproic acid treatment. On ex-
amination at age 4 years, he had bilateral ear pits, small
jaw, bilateral supernumerary nipples, abnormal foreskin
of the penis, undescended left testicle, intermittent eso-
tropia, and generalized spasticity with brisk reﬂexes. He
did not understand speech and was not able to walk or
talk. Brain MRI demonstrated a normal gyral pattern, dif-
fusely decreased white-matter volume, partial ACC with
thin posterior body and absent splenium, and normal cer-
ebellum (ﬁg. 1G–1I).
LR02-409.—This girl was born at 36wk gestationby emer-
gency cesarean section because of placenta previa, with a
birth weight 1.9 kg and length of 42 cm (both 3rd per-
centile). Her OFC was 33.3 cm at age 15 wk (4 SD for
corrected age of 11 wk) and fell to 5 SD by age 1 year.
She began having seizures at age 8 mo. At age 5 years, she
was small for her age, with weight of 10.45 kg (4 SD),
length of 93 cm (3 SD), and OFC of 41.5 cm (7 SD).
She was unable to walk or use any words, suggesting se-
vere mental retardation. On examination, she was strik-
ingly dysmorphic, with MIC, bitemporal narrowing, full
cheeks, prominent epicanthal folds, anteverted nares, and
tented upper lip with a long philtrum. She also had a
mixed sensorineural and conductive hearing loss, left eso-
tropia, and atrial septal defect. Brain MRI demonstrated a
normal gyral pattern, partial ACC with thin body and ab-
sent splenium, and mild CVH (ﬁg. 1J–1L).
LR05-101.—This boy was born at term after an uncom-
plicated pregnancy, except that a prenatal ultrasound at
22 wk gestation did not detect the septum pellucidum.
His birth weight was 3.88 kg (75th percentile), length was
54 cm (90th percentile), and OFC was 35 cm (50th per-
centile). Developmental delay and generalized hypotonia
were noted at age 3 mo because of lack of head control
and visual tracking, and seizures began at age ∼1 year. By
age 2 years, he had global developmental delay, axial hy-
potonia, limb spasticity, and poor feeding that required
placement of a nasogastric tube. He was not dysmorphic.
Examination revealed a small penis. Serial exams demon-
strated postnatal MIC, and his OFC was at the 25th per-
centile by age 3 mo and at the 2nd percentile by age 12
mo. His OFC at age 28 mo was 46.3 cm (2.5 SD). Brain
MRI demonstrated a normal gyral pattern, reduced white
matter, mildly enlarged and widely separated lateral ven-
tricles, complete ACC with Probst bundles along the me-
dial hemispheric walls, and mild CVH (ﬁg. 1M–1O).
Precise Mapping of Chromosome 1q Abnormalities by FISH
and aCGH
We mapped the 1q4 breakpoints of all six patients by ei-
ther BAC and fosmid FISH or by aCGH (ﬁg. 3).
LP94-079.—Chromosome analysis and FISH detected an
unbalanced translocation inherited from the proband’s fa-
ther: 46,XX,der(1)t(1;11)(q44;p15.3)pat. The extent of the
deletion was determined by mapping the chromosome 1
breakpoint of the balanced translocation in the father. The
clone RP11-518I10 (242.57–242.65 Mb) at 1q44 was split
between the translocation derivatives, indicating that all
DNA telomeric to this probe was present in one copy in
this child (ﬁg. 3).
LR04-249.—Chromosome analysis showed a large in-
terstitial deletion: 46,XY,del(1)(q42.1q44) de novo. FISH
analysis demonstrated that the deletion extended from
BAC clone RP11-87P4 (230.78–230.9 Mb) to RP11-399B15
(243.22–243.42 Mb), a region of 113 Mb.
LR05-202.—Chromosome analysis was interpreted asnor-
mal, but telomeric probes detected a de novo deletion of
1qter. aCGH demonstrated a large subtelomeric de novo
deletion beginning after BAC RP11-147E13 (ending at
235.38 Mb) and extending to the telomere, a distance of
11.9 Mb (ﬁg. 4). This deletion was also conﬁrmed using
LOH analysis with STRP (microsatellite) markers begin-
ning with marker D1S227 (215.36 Mb) and extending to
the subtelomeric marker D1S2682 (246.19 Mb). Some of
these interspersedmarkers were uninformative, since both
parents carried the same allele(s), but, for all of these, the
patient was homozygous for an allele carried by themother,
consistent with the pattern established by the unambig-
uously deleted markers (table 2).
LR06-076.—Chromosome analysiswas normal, butaCGH
detected a small deletion of 1q44 between BACs RP11-
158M3 (237.51–237.68 Mb) and RP11-606D18 (245.33–
245.50Mb), demonstrating a deletion of 7.6AMb between
237.68 Mb and 245.33 Mb. This interstitial deletion was
conﬁrmed by a second aCGH analysis and by LOHanalysis
(ﬁg. 4 and table 2).
LR02-409.—The initial chromosome analysis detected
an apparently balanced paracentric inversion of distal 1q.
In view of the girl’s phenotype, chromosome analysis was
repeated and demonstrated a complex rearrangement of
distal 1q, with two paracentric inversions 17.36Mb apart—
inv(1)(q32.2q42.2) and inv(1)(q43q44)—each containing
a small interstitial deletion. The proximal inversion ex-
tends from RP11-434B7 (211.48–211.60 Mb) in 1q32.2 to
RP11-99J16 (228.96–229.01 Mb) in 1q42.2, whereas the
distal inversion extends fromRP11-433N10 (236.57–236.76
Mb) in 1q43 to CTB-160H23 at 1q44. In addition, we found
two deletions in the region. The proximal 4-Mb deletion
was located in 1q41-q42.12 and included the clones RP11-
332J14 (218.70–218.87 Mb) and RP11-192M1 (224.12–
224.28 Mb). The distal deletion was located in 1q43-q44.
It included the clones RP11-553N16 (240.00–240.15 Mb)
and RP1-241M7 (242.49–242.57 Mb) and was ﬂanked by
the nondeleted clones RP11-80B9 (238.96–239.13 Mb)
and RP11-518L10 (242.57–242.65 Mb). The deletion is
therefore !3.5 Mb (ﬁg. 5). These deletions were conﬁrmed
with aCGH (ﬁg. 4). LOH analysis was performed without
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Figure 2. Brain-imaging abnormalities in patients with deletion
1q4, shown with head CT scan (A–C) or with T1-weighted midline
sagittal (D) and T2-weighted axial (E and F) MRI sequences in
patients LP94-079 (A–C) and LR04-249 (D–F). In patient LP94-
079, the cortex appears thickened in the posterior frontal and
perisylvian regions (white arrow[s] in panels A–C), suggesting PMG,
although the resolution is low. The lateral ventricles are located
in the normal position close to the midline (A and B), suggesting
that the corpus callosum is normal. The cerebellar vermis is small,
since it is not seen at the level of the low midbrain (white arrow-
head in panel A), and a small skull defect is seen beneath an
occipital cephalocele (white arrowhead in panel C). In LR04-249,
gyral pattern is poorly developed, even for 35 wk gestation, and
the corpus callosum is absent (white arrow in panel D and two
black arrows in panel E). The cerebellar vermis is small, with the
inferior margin (dashed line in panel D) well above the level of
the obex (solid line in panel D).
parental samples, but results were consistent with the de-
letion boundaries deﬁned by FISH and aCGH (table 2).
LR05-101.—Chromosome analysis demonstrated an ap-
parently balanced reciprocal translocation: 46,XY,t(1;13)-
(q44;q32) de novo. The breakpoint on 1q44 was mapped
to clone RP11-351N5 (241.98–242.13Mb), since this clone
gave signals on the normal chromosome 1, as well as both
derivative chromosomes in FISH experiments. This clone
contains the AKT3 gene (Ensembl). Fine mapping of the
chromosome 1 breakpoint with use of fosmid clones was
undertaken. The breakpoint was found to lie in clone
G248P89661B9 (242.08–242.12 Mb), a 38-kb clone whose
proximal end lies 4.5 kb upstream of the ﬁrst exon ofAKT3
(ﬁg. 5). The ZNF238 gene is located on the distal side of
the breakpoint, 210 kb away from AKT3 (ﬁg. 3). The chro-
mosome 13 breakpoint was mapped between fosmids
G248P81419A12 and G248P86855F5, a region that con-
tains no known genes. aCGH analysis demonstrated that
no deletions larger than two BACs were found in this pa-
tient (data not shown), consistent with the balanced trans-
location identiﬁed by FISH.
Sequencing of AKT3, UC.43, and ZNF238
We sequenced all 13 coding exons of AKT3, as well as an
ultraconserved element (UC.43) that lies within the ﬁrst
intron of AKT3. Ultraconserved elements such as UC.43
are deﬁned as sequences of 1200 bp with 100% conserva-
tion among human, rat, and mouse.16 All regions were
sequenced in at least 47 patients. No pathogenic muta-
tions were deﬁned. The sequence of UC.43 was normal in
43 patients. The remaining 4 of 47 patients, as well as 1
of 8 control subjects, had a heterozygous SNP (CrT at
position 111153 of AL662889). In addition, we sequenced
the ﬁrst 1,315 of 1,566 bp of the coding region of the
single exon of ZNF238 and found a heterozygous syn-
onymous substitution (val74val GTGrGTA) in one pa-
tient. Sequencing of AKT3 and ZNF238 for patient LR05-
101 with the t(1;13) translocation did not deﬁne any se-
quence changes in either the coding region or UTRs of
either gene. We were therefore unable to test for mono-
allelic versus biallelic expression of either gene in this
patient.
Developmental Expression of Akt3 and Znf238
RT-PCR and northern analysis data indicate that Akt3 and
Znf238 are both expressed in the adult mouse brain23,24;
however, developmental expression patterns have not been
reported for either gene. We therefore performed whole-
mount in situ hybridization duringmouse embryogenesis,
to determine whether these genes were expressed in the
developing mouse cortex. In agreement with the online
Brain Gene ExpressionMap (BGEM),25 we determined that
both genes are very widely expressed in the developing
CNS during embryogenesis, with high levels of expression
throughout the dorsal forebrain during E9.5–E15.5. In the
developing cortex, expression is observed both on the dor-
sal midline and laterally in the forming layers at E15.5.
Discussion
At least 30 patients with deletion of chromosome 1q42-
q44 have been reported, with consistent mental retarda-
tion of variable severity, frequent seizures, and numerous
congenital anomalies.19 The latter include up-slanting pal-
pebral ﬁssures, ear anomalies, small jaw, cleft palate, heart
malformations, abnormalities of the hands and feet, hypo-
spadias, and cryptorchidism. MIC was noted in 24 of 28
patients, although serial OFC measurements were rarely
noted. At least 12 patients had ACC, most with deletion
1q42- or 1q43-qter, but one interstitial deletion of 1q42
and one small terminal deletion of 1q44 have been re-
ported, suggesting the possibility of two separate loci.18,
19,26–29 In addition, two cousins with both deletion 1q44
and duplication 12p13.3 were reported with the cortical
malformation PMG.30 Two of the most consistent abnor-
malities in this syndrome have thus been MIC and ACC,
which suggests that one ormore genes involvedwithbrain
size and callosal development are found in this region.
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Figure 3. Precise delineation of chromosome rearrangements in distal 1q42-q44 in study patients. Deletion mapping of patients LR02-
409 and LR05-202 deﬁnes a minimal deleted region of 1.25 Mb between BACs RP11-657L23 and RP1-241M7. This region is deleted in
four patients, all of whom had ACC and MIC. Patient LP94-079 has a subtelomeric deletion that is distal to RP1-241M7 and had neither
ACC or MIC. In patient LR05-101, the breakpoint of the t(1;13) balanced de novo translocation lies within this region and is situated
with BAC clone RP11-351N5 and fosmid clone G248P89661B9. This is upstream of the ﬁrst exon of AKT3.
We have identiﬁed the secondmessenger-regulated serine-
threonine kinase AKT3 as a strong candidate gene for post-
natal MIC and ACC and as a probable contributor to
congenital MIC, on the basis of detailed physical-map-
ping studies and comparison with two separate Akt3
mouse knockouts.
Physical Mapping of 1q4 Deletions and Translocation
We identiﬁed an ∼3.5-Mb critical region deﬁned by the
centromeric and telomeric boundaries of the distal dele-
tion in subject LR02-249, who has both MIC and partial
ACC. This region is not shared by the deletion of subject
LP94-079, who has neither MIC nor ACC. This region ex-
tends from RP11-80B9 to RP11-241M7 (ﬁg. 3) and con-
tains 12 known genes: RGS7, FH, KMO, OPN3, EXO1,
MLP3C_HUMAN, NP_689879, CEP170, SDCCAG8, AKT3,
ZNF238, and NP_001013732. On the basis of reported ex-
pression in brain and lack of known associated pheno-
types (Ensembl), only a few of these—especially OPN3,
CEP171, AKT3, and ZNF238—are good candidates.We hy-
pothesize that haploinsufﬁciency of one or more of these
genes leads to MIC and ACC.
The 1q4 breakpoint of subject LR05-101, who also has
striking postnatal MIC and ACC associated with a bal-
anced reciprocal t(1;13) translocation, falls within this crit-
ical region. This breakpoint lies between the genes AKT3
and ZNF238 and is positioned ∼20 kb upstream of the ﬁrst
exon of AKT3 and ∼150 kb proximal to ZNF238. The ab-
sence of SNPs in either of these two mRNAs in subject
LR05-101 precluded the investigation of monoallelic ex-
pression in this boy. Disruption of gene expression by
chromosome breakpoints that are near but not within the
classically deﬁned area of a gene is a well-recognizedmech-
anism31,32 and suggests that, of the four genes deﬁned by
deletion mapping, AKT3 and ZNF238 represent the most
attractive positional candidates for a role inMIC andACC.
Our data do not suggest a single locus for CVH, since
patients LP94-079 and LR02-409 do not have overlapping
deletions. These data also suggest that the PMG-causative
gene is likely to be located in the most distal 4.5 Mb of
1q44.
Akt3 and Znf238 Are Widely Expressed in Brain
We have demonstrated through whole-mount in situ hy-
bridization inmouse that both Akt3 and Znf238 arewidely
expressed in the CNS during embryogenesis. We found
high levels of expression throughout the dorsal forebrain
(E9.5-E15.5) and in the developing cortex (E15.5), consis-
tent with the ﬁndings of others. Becker et al.24 studied the
expression pattern of Znf238 by northern blot and, in
Figure 4. aCGH demonstrating deletions (arrows) in patients with the 1q4 deletion. Data are represented as the corrected log2 ratios
between control and patient DNA. A, LR05-202. B, LR06-076. C, LR02-409. The distal region that is not deleted in LR06-076 is marked
with an arrowhead.
Table 2. LOH Analysis of Patients with the 1q4 Deletion
Marker
Position
LR05-202 LR05-202-1 LR05-202-2 LR06-076 LR06-076-1 LR06-076-2 LR02-409
Marshﬁeld
Map
(cM)
Starting
Chromosome
D1S227 238.52 1:215,361,062 70/70 (Heterozygous) 68/70 70/70 68/68 (Uninformative) 68/68 64/68 68/72 (Heterozygous)
D1S549_G 239.66 1:217,710,236 188/196 (Heterozygous) 188/196 188/188 184/188 (Heterozygous) 184/192 180/188 188/188
D1S2833 245.05 1:228,814,635 95/107 (Heterozygous) 95/95 105/107 97/97 (Hemizygous, maternal) 95/97 101/101 105/105
D1S2709 247.23 1:230,096,973 199/201 (Heterozygous) 195/201 197/199 195/199 (Heterozygous) 199/199 195/199 197/201 (Heterozygous)
D1S3462_G 247.23 1:230,017,109 231/237 (Heterozygous) 231/237 234/237 234/243 (Heterozygous) 237/243 231/234 231/243 (Heterozygous)
D1S2800 252.12 1:232,524,978 213/213 (Uninformative) 209/213 209/213 209/215 (Heterozygous) 202/209 215/215 215/217 (Heterozygous)
D1S235_G 254.64 1:233,960,378 202/213 (Heterozygous) 213/213 202/202 213/215 (Heterozygous) 213/213 215/219 202/202
D1S2850 256.26 1:234,697,246 152/152 (Uninformative) 152/156 152/152 154/154 (Uninformative) 154/154 150/154 150/154 (Heterozygous)
D1S2670 262.96 1:237,615,801 165/165 (Uninformative) 165/175 165/175 173/177 (Heterozygous) 177/177 165/173 165/175 (Heterozygous)
D1S2785 266.27 1:238,943,306 183/183 (Hemizygous, maternal) 183/183 179/179 177/177 (Hemizygous, maternal) 177/179 175/183 173/183 (Heterozygous)
D1S304 267.51 1:239,355,104 175/175 (Uninformative) 175/175 171/175 173/173 (Uninformative) 173/175 173/173 171/171
D1S2842 273.46 1:240,939,182 345/345 (Hemizygous, maternal) 345/351 341/353 349/349 (Hemizygous, maternal) 349/349 345/345 345/345
D1S1609_G 274.53 1:242,132,480 243/243 (Uninformative) 239/243 239/243 239/239 (Hemizygous, maternal) 239/239 243/248 248/248
D1S423 277.8 1:243,612,280 92/92 (Hemizygous, maternal) 92/94 94/94 92/92 (Uninformative) 92/92 92/92 92/92
D1S2836 285.75 1:244,936,701 256/256 (Hemizygous, maternal) 243/256 243/246 243/243 (Uninformative) 243/243 243/246 248/250 (Heterozygous)
D1S2682_G 288.29 1:246,196,829 149/149 (Hemizygous, maternal) 149/149 130/151 130/149 (Heterozygous) 130/130 130/149 130/145 (Heterozygous)
NOTE.—Allele sizes from the probands (LR05-202, LR06-076, and LR02-409), mothers (LR05-202-1 and LR06-076-1), and fathers (LR05-202-2 and LR06-076-2) are listed for each marker (with
associated interpretation). No DNA was available at the time of the study for the parents of proband LR02-409, so only heterozygosity is noted. Chromosome numbering is derived from the hg18
genome assembly (March 2006). Maternalpmaternally inherited region.
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Figure 5. FISH mapping of patients LR05-101 (A) and LR02-
409 (B–D). Analysis of LR05-101, who has a de novo 46,XY,t(1;13)-
(q44;q32) translocation, shows signals for fosmid G248P89661B9
(red) located on the normal and derived chromosomes 1, as well
as on the derived chromosome 13. This conﬁrms that it spans the
breakpoint on chromosome 1q44. Analysis of LR02-409 with probes
RP11-90B9 (green) and RP11-399B15 (red [B]) shows the distal
inversion, since the position of the two probes is reversed on the
two chromosome 1 homologs. The associated deletion inside the
distal inversion is demonstrated by loss of RP11-553N16 (red [C])
and by loss of RP11-411G13 (green [D]) compared with RP11-
438H8 (red [D]).
adult mice, found transcription only in the brain with the
highest levels in the cerebellum. The gene was also ex-
pressed in the head in mouse embryos, which suggests a
role in both the developing and mature CNS. Akt3 is more
highly expressed in brain than are its protein familymem-
bers Akt1 and Akt2 and is the predominant Akt protein
in cortex and hippocampus.23 In humans, AKT3 is ex-
pressed in brain, lungs, and kidneys in adults and in fetal
brain, heart and liver. These data suggest a role for both
AKT3 and ZNF238 in brain development and do not allow
further prioritization of these genes as ACC or MIC can-
didates on the basis of expression data alone.
ZNF238 is a C2H2-type zinc-ﬁnger protein for which
little functional information is available. It contains a Pox
virus and zinc ﬁnger (POZ) domain that functions as a
sequence-speciﬁc DNA-binding transcriptional repressor.24,
33,34 No animal models have been reported. A single highly
conserved noncoding sequence, designated “UC.43,” is lo-
cated in intron 1 of AKT3 but may regulate ZNF238 ex-
pression, since such noncoding sequences are preferen-
tially found near transcription factors.16
AKT3 Functions Downstream of PI3K and Regulates Brain
Size in Mice
Substantial functional data exist that support AKT3 as a
causative gene forMIC. The AKT or protein kinase B family
consists of three proteins that contain a pleckstrin-homol-
ogy domain (a phosphorylation substrate), a kinase do-
main, and a regulator domain, with the last identical in
all three AKT proteins (reviewed by Bellacosa et al.35). All
three AKT proteins function in a signaling pathway with
insulin or insulinlike growth factor 1 (IGF1), insulin re-
ceptor substrate (IRS), phosphoinositide-3-kinases (PI3K),
phophoinositide-3,4,5-triphosphate (PIP3), and phospho-
inositide-dependent protein kinases (PDPK1 and PDPK2),
to regulate many important cellular processes. These in-
clude transcription, cell proliferation, apoptosis, migra-
tion, glucose metabolism, and growth, including main-
tenance of both cell size and cell number.36–39 Overex-
pression of AKT proteins results in an increase in size of
various tissues, whereas deﬁciency results in defects in
growth and glucose regulation. For example, the Akt1/
mouse knockout has impaired overall growth (including
small brain size), whereas the Akt2/ mouse has insulin
intolerance and a diabetes-like syndrome.38,39
Two Akt3 mouse knockouts were recently reported, one
targeting exon 3 in an unstated strain of 129 mice that
we here designate “Akt3(ex3)/,”23 and the other targeting
exon 4 in 129 Ola mice that we designate “Akt3(ex4)/.”40
Body size and size of all organs other than the brain were
normal in both lines. In newborn mice, brain size was
normal in Akt3(ex4)/ mutants or was reduced by ∼15%
in Akt3(ex3)/ mutants. But postnatal growth was signif-
icantly reduced in both lines, with brain size reduced by
∼25% by age 3 mo, as measured by weight or volume. The
small size was caused by reductions in both cell size and
cell number. The cause of the reduced cell number may
be related to increased cell death, since exposure of pri-
mary hippocampal cell cultures fromAkt3(ex4)/mutants
to either glutamate or staurosporine increased the rate of
apoptosis.40 Akt3 also appears to have a role in callosal de-
velopment. One of the two mutant strains, Akt3(ex4)/,
had callosal hypoplasia, as assessed by both brain imaging
and pathological analysis,40 although the other strain did
not.23 This suggests a strain-speciﬁc effect on the pheno-
type. The same phenomenon was observed in our ﬁve
patients with deletion or disruption of AKT3: three had
total ACC, whereas two had partial ACC consisting of
overall reduced thickness and absent splenium (ﬁg. 1).
Thus, substantial functional data support a role for AKT3
in both prenatal and postnatal brain growth, as well as
corpus callosum development.
Deletion 1q4 Is Also Associated with CVH and PMG
All six patients also had CVH, but our data are difﬁcult
to reconcile with a single locus causing this phenotype.
Among the ﬁve patients with deletion 1q4 and CVH, only
BAC RP11-518L10 was deleted in all ﬁve patients. This
BAC contains all or portions of three known or potential
genes: cen-C1orf100-TGIF2P1-ADSS-tel. TGIF2P1 is a pseu-
dogene,ADSS (or adenylosuccinate synthetase) is involved
in purine biosynthesis, and C1orf100 is a predicted gene
of unknown function with no expression data available.
C1orf100 is not disrupted by the t(1;13) translocation in
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patient LR05-101, although the CVH in this boy is min-
imal. The next gene toward the centromere is ZNF238,
discussed above, but it is not contained in RP11-518L10.
Although it is possible that deletion of C1orf100 or the
adjacent ZNF238 is associated with CVH, the data are not
compelling. We think our data are more consistent with
the hypothesis that at least two genes contribute to CVH.
Patient LP94-079 has severe CVH with an occipital ce-
phalocele and has a deletion from RP11-518L10 to the 1q
telomere. We propose that one gene for CVH and another
causing PMG are located in this region. Alternatively, both
phenotypes could be caused by deletion of a single gene.
The remaining four patients have deletions for the same
3.5-Mb region between RP11-80B9 and RP11-241M7 (ﬁg.
3), discussed in regard to MIC and ACC. We propose that
a second gene causing CVH is located in this region. This
is not likely to be AKT3, since the reduced size of the
cerebellum in Akt3/ mutants is proportional to the re-
duced size of the cerebrum and also affects both vermis
and hemispheres similarly,40 in contrast to human CVH.
Deletion 1q4 is Consistently Associated with MIC and ACC
Our observations of both MIC and ACC in the children
reported here with deletion 1q4 support a role for AKT3
(less likely ZNF238) in human brain growth and callosal
development (table 1). There are two further reports of
patients with large 1q4 deletions that included AKT3 and
ZNF238. The ﬁrst had an ∼15-Mb subtelomeric deletion,18
whereas the second had an ∼8.5-Mb subtelomeric deletion
involving the RGS7 gene to the telomere.19 Both had MIC
and partial ACC, as determined by cranial CT scan. The
former consisted of congenital MIC (2 or3 SD) in both
children and postnatal MIC (4 SD) at age 8 mo in the
child who survived. Importantly, the boy with putative
disruption of AKT3 expression by the nearby t(1;13) break-
point had normal (mean) OFC at birth, but it was 2 SD
by age 1 year and 2.5 SD by age 2 years. This is com-
parable to data in the mouse Akt3/ mutants. When our
data are combined with the literature, at least four patients
with deletion 1q42-q44 that include AKT3 have had con-
genital MIC (2 to 5 SD), with at least two more dem-
onstrating additional postnatal slowing of head growth
(table 1). By contrast, another patient with a 1q4 deletion
distal to AKT3 had normal OFC at age 15 years (table 1).
In summary, we believe that several complementary lines
of evidence support AKT3 as an excellent candidate gene
for both MIC and ACC in humans. We suggest that hap-
loinsufﬁciency of AKT3 causes postnatal MIC in humans
and may contribute to congenital MIC as well.
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